Showing results (1-10 of 267) with videos related to
Sort By:
Pageof 27
Obstetrics and Gynecology|September 1, 1976
Preoperative and intraoperative evaluation in ovarian malignancyM S Piver, J J BarlowObstetrics and Gynecology|May 1, 1977
Single agent vs combination chemotherapy in the treatment of ovarian cancerJ J Barlow, M S PiverCancer|March 1, 1977
High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervixM S Piver, J J BarlowCancer Treatment Reports|May 1, 1976
Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancerJ J Barlow, M S PiverCancer Treatment Reports|February 1, 1979
Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary reportM S Piver, J J Barlow, M BhattacharyaObstetrics and Gynecology|September 1, 1980
Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary reportM S Piver, S Lele, J J BarlowCancer Treatment Reports|January 1, 1981
Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinomaM S Piver, S Lele, J J BarlowAmerican Journal of Obstetrics and Gynecology|March 1, 1981
Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinomaM S Piver, J J Barlow, R KrishnamsettyCancer Treatment Reports|April 1, 1980
Doxorubicin, cyclophosphamide, and 5-fluorouracil in patients with carcinoma of the cervix or vaginaM S Piver, J J Barlow, J DunbarObstetrics and Gynecology|July 1, 1978
Incidence of subclinical metastasis in stage I and II ovarian carcinomaM S Piver, J J Barlow, S B LelePageof 27